Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSCT for Malignant Infantile Osteopetrosis
NCT01087398Phase 3Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2009
- Primary completion
- Nov 2012
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of hematopoietic stem cells in malignant infantile osteopetrosis (MIOP), sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
hematopoietic stem cells
03
Conditions
malignant infantile osteopetrosis (MIOP)
Beyond the preview
Go deeper on NCT01087398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01087398.